Dividends CalendarEarnings Calendar

NTLA | Intellia Therapeutics Inc

62.58 -7.36 (-13.33%) 
Intellia Therapeutics Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Cambridge, Massachusetts, United States
  • Number of employees::   104

Company profile

Our company?s name is derived from the Greek word, Entelia, meaning a situation of excellence; without fault, having all the required elements, qualities or characteristics.

About the Company

Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

  • Revenue: 20.92M


40 Erie Street
Suite 130
Cambridge, MA 02139
United States

    Key Persons / Board of Directors

    • CEO :  Nessan Bermingham, PhD
    • General Counsel :  José Rivera

    Jump to (Finance sites)


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.

    BUY 25
    HOLD 75
    SELL 0

    Their Official Profiles 


    Peers / Similar stocks 


    Other stocks 

    ibm tgt aap sig pdco azo tvpt low afsi amg cgc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 

    Recommended Books

    Technical Analysis For Dummies
    Buy on Amazon

    Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.

    A simple, straightforward guide to the fundamentals of technical analysis